Main Takeaway: Pfizer earned 42 cents per share for the fourth quarter, 6 cents a share below estimates. "The Pfizer news represents a new chapter for the market," the "Mad Money" host said.

Jim Cramer On Investing Amid A Still Fluid Covid 19 Vaccine Rollout -

Pfizer earned 42 cents per share for the fourth quarter, 6 cents a share below estimates. "The Pfizer news represents a new chapter for the market," the "Mad Money" host said. First Horizon CEO Bryan Jordan appeared Friday on "Mad Money," joining CNBC's

Important details found

  • Pfizer earned 42 cents per share for the fourth quarter, 6 cents a share below estimates.
  • "The Pfizer news represents a new chapter for the market," the "Mad Money" host said.
  • First Horizon CEO Bryan Jordan appeared Friday on "Mad Money," joining CNBC's

Why this topic is useful

Readers often search for Jim Cramer On Investing Amid A Still Fluid Covid 19 Vaccine Rollout because they want a clearer explanation, related examples, and a practical way to continue exploring the topic.

Sponsored

Frequently Asked Questions

How should readers use this information?

Use it as a starting point, then open related pages for more specific details.

What should readers check next?

Readers should check related pages, official references, or updated sources when details matter.

Why are related topics included?

Related topics help readers compare nearby references and understand the broader subject.

Topic Gallery

Jim Cramer on investing amid a 'still fluid' Covid-19 vaccine rollout
Jim Cramer: Fixing the Covid-19 vaccine rollout is crucial for markets, economy
Jim Cramer on airline stocks, Boeing and Covid-19 vaccine rollout
Jim Cramer on how the Fed, Covid-19 vaccine rollout are impacting markets
Jim Cramer on the Pfizer Covid-19 vaccine rollout: 'This is a historic moment'
Jim Cramer: Coronavirus stocks came back with a 'vengeance'
First Horizon CEO on Covid-19 vaccine rollout, economic recovery, tech innovation for banks
Jim Cramer expects a 'multiday sell-off in the Covid names'
Jim Cramer breaks down stocks of companies in the race to develop a coronavirus vaccine
Jim Cramer on Pfizer's Q4 earnings and full-year guidance
Sponsored
View Full Details
Jim Cramer on investing amid a 'still fluid' Covid-19 vaccine rollout

Jim Cramer on investing amid a 'still fluid' Covid-19 vaccine rollout

Read more details and related context about Jim Cramer on investing amid a 'still fluid' Covid-19 vaccine rollout.

Jim Cramer: Fixing the Covid-19 vaccine rollout is crucial for markets, economy

Jim Cramer: Fixing the Covid-19 vaccine rollout is crucial for markets, economy

Read more details and related context about Jim Cramer: Fixing the Covid-19 vaccine rollout is crucial for markets, economy.

Jim Cramer on airline stocks, Boeing and Covid-19 vaccine rollout

Jim Cramer on airline stocks, Boeing and Covid-19 vaccine rollout

Read more details and related context about Jim Cramer on airline stocks, Boeing and Covid-19 vaccine rollout.

Jim Cramer on how the Fed, Covid-19 vaccine rollout are impacting markets

Jim Cramer on how the Fed, Covid-19 vaccine rollout are impacting markets

Read more details and related context about Jim Cramer on how the Fed, Covid-19 vaccine rollout are impacting markets.

Jim Cramer on the Pfizer Covid-19 vaccine rollout: 'This is a historic moment'

Jim Cramer on the Pfizer Covid-19 vaccine rollout: 'This is a historic moment'

After months of research and clinical trials, the Pfizer-BioNTech

Jim Cramer: Coronavirus stocks came back with a 'vengeance'

Jim Cramer: Coronavirus stocks came back with a 'vengeance'

Read more details and related context about Jim Cramer: Coronavirus stocks came back with a 'vengeance'.

First Horizon CEO on Covid-19 vaccine rollout, economic recovery, tech innovation for banks

First Horizon CEO on Covid-19 vaccine rollout, economic recovery, tech innovation for banks

First Horizon CEO Bryan Jordan appeared Friday on "Mad Money," joining CNBC's

Jim Cramer expects a 'multiday sell-off in the Covid names'

Jim Cramer expects a 'multiday sell-off in the Covid names'

"The Pfizer news represents a new chapter for the market," the "Mad Money" host said. Subscribe to CNBC PRO for access to ...

Jim Cramer breaks down stocks of companies in the race to develop a coronavirus vaccine

Jim Cramer breaks down stocks of companies in the race to develop a coronavirus vaccine

Read more details and related context about Jim Cramer breaks down stocks of companies in the race to develop a coronavirus vaccine.

Jim Cramer on Pfizer's Q4 earnings and full-year guidance

Jim Cramer on Pfizer's Q4 earnings and full-year guidance

Pfizer earned 42 cents per share for the fourth quarter, 6 cents a share below estimates. Pfizer's revenue was above forecasts, ...